| |
| |
|
| Insider
Information: |
Davis George Eric |
| Relationship: |
EVP, Chief Legal Officer |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
56,157 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,977,195 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,157 |
|
|
| Total
Value |
$4,977,195 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Legal Officer |
2024-05-02 |
56,157 |
2007-02-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
223 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-06-05 |
4 |
S |
$91.04 |
$862,230 |
D/D |
(9,471) |
74,342 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2016-05-13 |
4 |
D |
$82.71 |
$90,650 |
D/D |
(1,096) |
74,444 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, General Counsel |
• – – |
2015-04-30 |
4 |
A |
$51.26 |
$37,422 |
D/D |
730 |
74,576 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-09-13 |
4 |
S |
$99.57 |
$1,194,840 |
D/D |
(12,000) |
74,950 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-22 |
4 |
D |
$88.05 |
$291,357 |
D/D |
(3,309) |
75,253 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2016-05-10 |
4 |
S |
$86.32 |
$402,079 |
D/D |
(4,658) |
75,540 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2016-11-18 |
4 |
OE |
$38.59 |
$192,950 |
D/D |
5,000 |
75,798 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-03-15 |
4 |
D |
$92.50 |
$277,038 |
D/D |
(2,995) |
75,967 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,420 |
76,097 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2016-03-14 |
4 |
S |
$86.21 |
$172,079 |
D/D |
(1,996) |
76,190 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-15 |
4 |
D |
$94.53 |
$628,435 |
D/D |
(6,648) |
77,099 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-03-20 |
4 |
D |
$73.05 |
$241,722 |
D/D |
(3,309) |
77,842 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-04-30 |
4 |
A |
$62.59 |
$21,217 |
D/D |
339 |
78,181 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2016-03-03 |
4 |
D |
$89.57 |
$195,263 |
D/D |
(2,180) |
78,186 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,586 |
78,295 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-19 |
4 |
AS |
$93.92 |
$742,625 |
D/D |
(7,907) |
78,562 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-03-06 |
4 |
AS |
$93.32 |
$139,793 |
D/D |
(1,498) |
78,962 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,040 |
79,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, General Counsel |
• – – |
2014-10-30 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
79,426 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2016-05-09 |
4 |
S |
$84.55 |
$845,532 |
D/D |
(10,000) |
80,198 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2016-02-29 |
4 |
D |
$81.87 |
$1,445,497 |
D/D |
(17,656) |
80,366 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Legal Officer |
• – – |
2023-03-16 |
4 |
D |
$93.41 |
$1,864,183 |
D/D |
(19,957) |
80,367 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Legal Officer |
• – – |
2024-03-15 |
4 |
D |
$83.87 |
$1,819,895 |
D/D |
(21,699) |
80,458 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Legal Officer |
• – – |
2023-05-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
210 |
80,474 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, General Counsel |
• – – |
2014-02-20 |
4 |
OE |
$21.51 |
$430,200 |
D/D |
20,000 |
80,656 |
0 |
- |
|
223 Records found
|
|
Page 7 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
